1. Home
  2. WKHS vs ANEB Comparison

WKHS vs ANEB Comparison

Compare WKHS & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$3.50

Market Cap

17.4M

ML Signal

HOLD

Logo Anebulo Pharmaceuticals Inc.

ANEB

Anebulo Pharmaceuticals Inc.

HOLD

Current Price

$0.36

Market Cap

19.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKHS
ANEB
Founded
2007
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
19.4M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
WKHS
ANEB
Price
$3.50
$0.36
Analyst Decision
Hold
Hold
Analyst Count
1
1
Target Price
$21.00
N/A
AVG Volume (30 Days)
69.6K
94.9K
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.88
EPS
N/A
N/A
Revenue
$763,173.00
N/A
Revenue This Year
$81.01
N/A
Revenue Next Year
$34.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$0.35
52 Week High
$11.80
$3.42

Technical Indicators

Market Signals
Indicator
WKHS
ANEB
Relative Strength Index (RSI) 36.86 17.01
Support Level $0.90 N/A
Resistance Level $6.00 $0.51
Average True Range (ATR) 0.22 0.05
MACD 0.01 0.02
Stochastic Oscillator 37.66 0.05

Price Performance

Historical Comparison
WKHS
ANEB

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: